M. Andreuccetti

2.5k citations
28 papers · 1.9k · 1 hit paper · h-index 14

Impact in

  • Hepatology top 1%
    • Hepatocellular Carcinoma Treatment and Prognosis
  • Oncology top 2%
    • Colorectal Cancer Treatments and Studies
    • Cancer Treatment and Pharmacology
    • Pancreatic and Hepatic Oncology Research
    • Colorectal Cancer Surgical Treatments

Papers in

    • Colorectal Cancer Treatments and Studies 13
    • Cancer Treatment and Pharmacology 7
    • Lung Cancer Research Studies 2
    • Lung Cancer Treatments and Mutations 5
    • Gastric Cancer Management and Outcomes 3
    • Prostate Cancer Treatment and Research 2

M. Andreuccetti

28 papers receiving 1.8k citations

M. Andreuccetti's Hit Papers

Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest 2007 · 906 citations
9060+6+12Years since publication250500750

Peers

M. Andreuccetti
Comparison fields: 5 of 77
  • Hepatology 650
  • Oncology 1.2k
  • Pulmonary and Respiratory Medicine 356
  • Cancer Research 104
  • Genetics 74
Replace R. Adam with:
R. Adam France
C. Couteau France
José María Viéitez Spain
Shinichi Ohkawa Japan
E. Pfanner Italy
Massimo Lopez Italy
José Barrueco United States
Ірина Давиденко United States
Philipp K. Haber Germany
Adriana Romiti Italy
M. Andreuccetti relative to R. Adam France R. Adam's profile →
Citations per field
00.5×3.9×
R. Adam · 1×
Citations per year

Countries citing papers authored by M. Andreuccetti

Since Specialization
Citations

This map shows the geographic impact of M. Andreuccetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Andreuccetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Andreuccetti more than expected).

Fields of papers citing papers by M. Andreuccetti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Andreuccetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Andreuccetti. The network helps show where M. Andreuccetti may publish in the future.

Co-authors

The 25 scholars most cited alongside M. Andreuccetti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. Andreuccetti Line = papers co-authored together M. Andreuccetti links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest
Hit paper breakdown →
2007906
2 2010193
3 2009177
4 2010145
5 200494
6 200856
7
Sorafenib plus daily low-dose temozolomide for relapsed glioblastoma: a phase II study.
201355
8 199650
9 200434
10 200931
11 199625
12 201124
13 200622
14 199720
15 201012
16 200411
17 20088
18 19947
19 20105
20 20074

About M. Andreuccetti

M. Andreuccetti is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Hepatology and Genetics, having authored 28 papers that have together received 1.9k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (13 papers), Cancer Treatment and Pharmacology (7 papers), Lung Cancer Treatments and Mutations (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Gastric Cancer Management and Outcomes (3 papers), Prostate Cancer Treatment and Research (2 papers), Lung Cancer Research Studies (2 papers) and Glioma Diagnosis and Treatment (2 papers). The work is most often cited by research in Hepatology (650 citations), Oncology (1.2k citations), Pulmonary and Respiratory Medicine (356 citations), Cancer Research (104 citations) and Genetics (74 citations). M. Andreuccetti has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Alfredo Falcone, Gianluca Masi, I. Brunetti, Cristina Granetto, Giacomo Allegrini, Enrico Cortesi, Sergio Ricci, Cinzia Orlandini, Lucio Crinò and Luisa Fioretto. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, British Journal of Cancer, European Journal of Cancer and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact